Medicine guide

Dabigatran Spirig HC 150 mg

As listed in the register: Dabigatran Spirig HC 150 mg, Hartkapseln

150 mg ·

  • Prescription only
  • Blood, clotting and anaemia
Active substance
Dabigatranum etexilatum
Made by
Spirig HealthCare AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

Details

Made bySpirig HealthCare AG
Active substanceDabigatranum etexilatum
Used inBlood, clotting and anaemia
Strength150 mg
ClassificationB01AE07 · Blood, clotting and anaemia
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerDabigatran Spirig HC 150 mg, Hartkapseln
Packs60 Kapsel(n) · 180 Kapsel(n) · 60 Kapsel(n)
Zulassungsnummer69055
Dosisstärke2

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.